Replies to post #35027 on Relief Therapeutics Holding AG (RLFTF)

[DonDonDonDon]

BECAUSE they wouldn't move forward with that study if intravenous VIP (RLF-100) wasn't a slam dunk

The opposite might be true. Maybe the inhaler trial is starting because the IV trial was a failure. Plan B.